Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
78975105 | 7897510 | 5 | F | 20150802 | 20160802 | 20110413 | 20160805 | EXP | PHHY2011CA27486 | NOVARTIS | 73.17 | YR | F | Y | 0.00000 | 20160805 | CN | COUNTRY NOT SPECIFIED | CA |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
78975105 | 7897510 | 1 | PS | SANDOSTATIN LAR DEPOT | OCTREOTIDE ACETATE | 1 | Intramuscular | 30 MG, QMO | U | 21008 | 30 | MG | /month | ||||||
78975105 | 7897510 | 2 | C | BABY ASPIRIN | ASPIRIN | 1 | Unknown | U | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
78975105 | 7897510 | 1 | Neuroendocrine tumour |
78975105 | 7897510 | 2 | Anticoagulant therapy |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
78975105 | 7897510 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
78975105 | 7897510 | Anorectal discomfort | |
78975105 | 7897510 | Blood pressure increased | |
78975105 | 7897510 | Diarrhoea | |
78975105 | 7897510 | Injection site haemorrhage | |
78975105 | 7897510 | Injection site mass | |
78975105 | 7897510 | Pain in jaw |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
78975105 | 7897510 | 1 | 20100621 | 0 |